Novo Nordisk UK, in agreement with the Medicines and Healthcare products Regulatory Agency (MHRA) and the Department of Health and Social Care (DHSC) would like to inform you of the following: Due to a drug shortage for Norditropin, Novo Nordisk has decided to: • discontinue the production of Norditropin NordiFlex 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5 ml immediately and permanently • pause production of Norditropin FlexPro 5mg/1.5ml ONLY to assist with establishing a more consistent supply of Norditropin FlexPro 10mg/1.5ml and Norditropin FlexPro 15mg/1.5ml. Please refer to the Medicines Supply tool (SPS) for up to date information and advice from the DHSC.